New Key Statistics Module, Z-Score and F-Score
AMEX:AEON Key Ratios
Market Cap $ M | 34.66 |
Enterprise Value $ M | 45.99 |
P/E(ttm) | 0.84 |
PE Ratio without NRI | -- |
Forward PE Ratio | 1.17 |
Price/Book | -- |
Price/Sales | -- |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | -- |
EPS (TTM) $ | 1.05 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -2.53 |
EV-to-EBITDA | -2.54 |
PEG | -- |
Shares Outstanding M | 39.52 |
Net Margin (%) | -- |
Operating Margin % | -- |
Pre-tax Margin (%) | -- |
Quick Ratio | 0.39 |
Current Ratio | 0.39 |
ROA % (ttm) | 554.85 |
ROE % (ttm) | 10,000.00 |
ROIC % (ttm) | -617.78 |
Dividend Yield % | -- |
Altman Z-Score | -- |
AEON Number of Guru Trades
AEON Volume of Guru Trades
Gurus Latest Trades with AMEX:AEON
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
AMEX:AEON is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
AEON Biopharma Inc Insider Transactions
No Available Data
News about AMEX:AEON
Total 0- 1